Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moanaro Biswas

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Cellular Immunology|February 6, 2023
Suppression of anti-drug antibody formation against coagulation factor VIII by oral delivery of anti-CD3 monoclonal antibody in hemophilia A miceThais B Bertolini, Roland W Herzog, Sandeep R P Kumar, et al.
Molecular Therapy. Methods & Clinical Development|March 5, 2024
B cell focused transient immune suppression protocol for efficient AAV readministration to the liverJyoti Rana, Roland W Herzog, Maite Muñoz-Melero, et al.
Frontiers in Immunology|November 13, 2023
Distinct functions and transcriptional signatures in orally induced regulatory T cell populationsMoanaro Biswas, Kaman So, Thais B Bertolini, et al.
Frontiers in Immunology|July 16, 2025
CXCR5 engineered human and murine Tregs for targeted suppression in secondary and tertiary lymphoid organsMatteo Doglio, Jyoti Rana, Adriana Stucchi, et al.
Molecular Therapy. Methods & Clinical Development|November 4, 2020
Engineering and <i>In Vitro</i> Selection of a Novel AAV3B Variant with High Hepatocyte Tropism and Reduced SeroreactivityMoanaro Biswas, Damien Marsic, Ning Li, et al.
Blood|May 5, 2017
Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8<sup>+</sup> T cellsGeoffrey L Rogers, Jamie L Shirley, Irene Zolotukhin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 17, 2026
Transient prophylactic immunosuppression with abatacept or dasatinib prevents immune responses in AAV gene transferRebecca Xicluna, Kentaro Yamada, Miguel Gonzalez-Visiedos, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 6, 2023
TLR9-independent CD8<sup>+</sup> T cell responses in hepatic AAV gene transfer through IL-1R1-MyD88 signalingSandeep R P Kumar, Moanaro Biswas, Di Cao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 13, 2022
IL-15 blockade and rapamycin rescue multifactorial loss of factor VIII from AAV-transduced hepatocytes in hemophilia A miceJohn S S Butterfield, Kentaro Yamada, Thais B Bertolini, et al.
Blood|May 16, 2023
Factor VIII trafficking to CD4+ T cells shapes its immunogenicity and requires several types of antigen-presenting cellsRadoslaw Kaczmarek, Annie R Piñeros, Paige E Patterson, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Cellular Immunology|February 6, 2023
Suppression of anti-drug antibody formation against coagulation factor VIII by oral delivery of anti-CD3 monoclonal antibody in hemophilia A miceThais B Bertolini, Roland W Herzog, Sandeep R P Kumar, et al.
Molecular Therapy. Methods & Clinical Development|March 5, 2024
B cell focused transient immune suppression protocol for efficient AAV readministration to the liverJyoti Rana, Roland W Herzog, Maite Muñoz-Melero, et al.
Frontiers in Immunology|November 13, 2023
Distinct functions and transcriptional signatures in orally induced regulatory T cell populationsMoanaro Biswas, Kaman So, Thais B Bertolini, et al.
Frontiers in Immunology|July 16, 2025
CXCR5 engineered human and murine Tregs for targeted suppression in secondary and tertiary lymphoid organsMatteo Doglio, Jyoti Rana, Adriana Stucchi, et al.
Molecular Therapy. Methods & Clinical Development|November 4, 2020
Engineering and <i>In Vitro</i> Selection of a Novel AAV3B Variant with High Hepatocyte Tropism and Reduced SeroreactivityMoanaro Biswas, Damien Marsic, Ning Li, et al.
Blood|May 5, 2017
Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8<sup>+</sup> T cellsGeoffrey L Rogers, Jamie L Shirley, Irene Zolotukhin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 17, 2026
Transient prophylactic immunosuppression with abatacept or dasatinib prevents immune responses in AAV gene transferRebecca Xicluna, Kentaro Yamada, Miguel Gonzalez-Visiedos, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 6, 2023
TLR9-independent CD8<sup>+</sup> T cell responses in hepatic AAV gene transfer through IL-1R1-MyD88 signalingSandeep R P Kumar, Moanaro Biswas, Di Cao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 13, 2022
IL-15 blockade and rapamycin rescue multifactorial loss of factor VIII from AAV-transduced hepatocytes in hemophilia A miceJohn S S Butterfield, Kentaro Yamada, Thais B Bertolini, et al.
Blood|May 16, 2023
Factor VIII trafficking to CD4+ T cells shapes its immunogenicity and requires several types of antigen-presenting cellsRadoslaw Kaczmarek, Annie R Piñeros, Paige E Patterson, et al.
Pageof 5